Metabolic alterations have been implicated in the etiology of temporal lobe epilepsy (TLE), but whether or not they have a functional impact on cellular energy producing pathways (glycolysis and/or oxidative phosphorylation) is unknown. The goal of this study was to determine if alterations in cellular bioenergetics occur using realtime analysis of mitochondrial oxygen consumption and glycolytic rates in an animal model of TLE. We hypothesized that increased steady-state levels of reactive oxygen species (ROS) initiated by epileptogenic injury result in impaired mitochondrial respiration. We established methodology for assessment of bioenergetic parameters in isolated synaptosomes from the hippocampus of Sprague-Dawley rats at various times in the kainate (KA) model of TLE. Deficits in indices of mitochondrial respiration were observed at time points corresponding with the acute and chronic phases of epileptogenesis. We asked if mitochondrial bioenergetic dysfunction occurred as a result of increased mitochondrial ROS and if it could be attenuated in the KA model by pharmacologically scavenging ROS. Increased steady-state ROS in mice with forebrain-specific conditional deletion of manganese superoxide dismutase (Sod2 fl/fl NEX Cre/Cre ) in mice resulted in profound deficits in mitochondrial oxygen consumption. Pharmacological scavenging of ROS with a catalytic antioxidant restored mitochondrial respiration deficits in the KA model of TLE. Together, these results demonstrate that mitochondrial respiration deficits occur in experimental TLE and ROS mechanistically contribute to these deficits. Furthermore, this study provides novel methodology for assessing cellular metabolism during the entire time course of disease development.
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Introduction
Metabolic impairment underlies the etiology of various neurological disorders such as Alzheimer's disease, Parkinson's disease, traumatic brain injury and stroke (Beal, 2004; Rahman, 2012) . Its role in the etiology of epilepsy is receiving increased attention (Kudin et al., 2002; Kovac et al., 2012; Rowley and Patel, 2013) . Epilepsy is one of the most common neurological disorders with an incidence of~1% in the population (Delgado-Escueta et al., 1999) . Temporal lobe epilepsy (TLE), a form of acquired epilepsy is usually triggered by an insult such as brain injury and the development of chronic seizures after a silent period devoid of seizures. The process by which epilepsy develops i.e. epileptogenesis is known to involve multiple molecular and physiological changes that alter brain circuitry to promote excitability. In human TLE, two characteristic changes in metabolism are known to occur, the mechanistic basis of which is unclear. First, glucose utilization or increased metabolism occurs during seizures or ictal events. Secondly, the period between seizures or interictal period is typified by glucose hypometabolism (Chugani et al., 1994; Lee et al., 2012) . Attempts to understand the role of glucose overutilization during seizures have led to studies demonstrating the anticonvulsant effects of limiting glycolysis with 2-deoxyglucose, fructose 1,6 bisphosphate or ketogenic diets (Bough et al., 2006; Lian et al., 2007; Stafstrom et al., 2009) .
Multiple lines of evidence support a role of mitochondria in the development of epilepsy, which was first recognized by the occurrence of epilepsy in patients with inherited mitochondrial disorders (Wallace et al., 1988; Mecocci et al., 1993) . Almost all known functions of mitochondria have a capacity to impact epilepsy, but ATP production and the generation of reactive oxygen species (ROS) are prime candidates due to the energy demands of seizures and sensitivity of mitochondrial processes to oxidative damage. In studies of patients with TLE, the role of mitochondria has been suggested by inhibition of complex I of the electron transport chain (ETC) and reduction in N-acetyl aspartate levels in the hippocampus (Kunz et al., 2000; Vielhaber et al., 2008) . Recent work from our group has shown increases in production of mitochondrial ROS, reactive nitrogen species (RNS), oxidative damage to Neurobiology of Disease 75 (2015) 151-158 
